Updated Jul 16, 2026
O'Toole David D has filed 4 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $69K. Historical track record: 3/5 stars across 6 tracked purchases.
David D O'Toole serves as the Chief Financial Officer (CFO) of Avita Medical, Inc., a company known for its innovative RECELL system for burn treatment. He has been involved in multiple SEC filings related to the company, indicating his role in financial oversight.
| Role | Insider |
|---|---|
| Notability | 20/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★☆☆ (3/5) |
|---|---|
| Total purchases tracked | 6 |
| Purchases with forward-return data | 6 |
| 30-day win rate | 6667% |
| 90-day win rate | 0% |
| Avg 5-day return | +438.52% |
| Avg 30-day return | +170.75% |
| Avg 90-day return | -2073.37% |
| Best 30-day return | +1688.60% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | RCEL | AVITA Medical, Inc. | A — Grant or award | 2.0K | $3.97 | $8K |
| 2026-06-01 | RCEL | AVITA Medical, Inc. | A — Grant or award | 5.0K | $3.05 | $15K |
| 2026-05-20 | RCEL | AVITA Medical, Inc. | P — Open-market purchase | 2.0K | $4.26 | $9K |
| 2026-05-19 | RCEL | AVITA Medical, Inc. | P — Open-market purchase | 2.0K | $4.24 | $8K |
| 2026-03-11 | RCEL | AVITA Medical, Inc. | P — Open-market purchase | 1.8K | $4.78 | $9K |
| 2026-02-23 | RCEL | AVITA Medical, Inc. | P — Open-market purchase | 3.0K | $4.15 | $12K |
| 2026-02-19 | RCEL | AVITA Medical, Inc. | A — Grant or award | 105.5K | — | |
| 2025-08-26 | RCEL | AVITA Medical, Inc. | P — Open-market purchase | 2.0K | $4.52 | $9K |
| 2025-08-12 | RCEL | AVITA Medical, Inc. | P — Open-market purchase | 2.0K | $4.81 | $10K |
| 2024-12-05 | RCEL | AVITA Medical, Inc. | P — Open-market purchase | 500 | $12.40 | $6K |
| 2024-12-05 | RCEL | AVITA Medical, Inc. | P — Open-market purchase | 475 | $12.53 | $6K |
| 2024-12-05 | RCEL | AVITA Medical, Inc. | A — Grant or award | 785 | $7.83 | $6K |
David D O'Toole serves as the Chief Financial Officer (CFO) of Avita Medical, Inc., a company known for its innovative RECELL system for burn treatment. He has been involved in multiple SEC filings related to the company, indicating his role in financial oversight.…
4 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 8 open-market purchases ($69K) and 0 open-market sales () across all tracked filings.
Across 6 tracked purchases, O'Toole David D averaged +170.7% avg 30-day return with a 6667% 30-day win rate. InsiderAlpha rates the track record at 3/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live O'Toole David D profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.